For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250404:nRSD7171Da&default-theme=true
RNS Number : 7171D Reach PLC 04 April 2025
4 April 2025
Reach plc
(the Company)
Purchase of Shares for the Employee Benefit Trust
The Company has been notified by the Trustee of the Reach Employee Benefit
Trust (EBT) that the EBT has purchased a total of 414,174 Ordinary Shares of
10p each in the Company. Further detail is set out below.
This purchase is in line with the position confirmed to shareholders at the
2024 AGM that the Company intends to buy shares into the EBT when it is
appropriate to do so to aid the management of overall dilution from share
plans.
Date Exchange Number of shares Price per share
(pence)
2 April 2025 XLON 275,000 72.2
3 April 2025 XLON 139,174 71.3947
The average price of the above purchases was 71.79735 pence per share.
The shares will be held in the EBT, which is a discretionary trust for the
benefit of the Group's employees. The shares will be used to satisfy the
exercise of share options by employees or the release of restricted shares,
including to Persons Discharging Managerial Responsibility (PDMRs) of the
Company.
Further to this purchase, the EBT holds a total of 2,743,291 Ordinary Shares
which represents 0.86% of the Company's issued share capital. The total number
of Ordinary Shares of 10p each in issue (excluding treasury shares) is
318,157,956.
The Company will continue to keep this under review, and will look to make
further purchases into the EBT when it is appropriate to do so.
Enquiries
Reach plc
Piers North, Chief Executive Officer 020 7293 3000
Darren Fisher, Chief Financial Officer
Laura Harris, Group Company Secretary
Teneo
Giles Kernick 020 7353 4200
LEI: 213800GNI5XF3XOATR61
Classification: 3.1 Additional regulated information required to be disclosed
under the laws of the United Kingdom
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSUPUPUCUPAUBC